Arcus Biosciences to Present at Two Key Healthcare Conferences in March
Event summary
- Arcus Biosciences will participate in Leerink Global Healthcare Conference on March 9, 2026.
- The company will also attend Barclays 28th Annual Global Healthcare Conference on March 10, 2026.
- Both events include fireside chats and one-on-one meetings with investors.
- Live webcast of the fireside chat available via Arcus Biosciences' website.
The big picture
Arcus Biosciences' participation in these high-profile conferences underscores the company's focus on engaging with investors as it advances its late-stage clinical programs. The events provide a platform for Arcus to highlight its differentiated molecules and combination therapies amid a competitive landscape in cancer and inflammatory disease treatments.
What we're watching
- Pipeline Progress
- How updates on casdatifan and quemliclustat trials will impact investor sentiment.
- Market Positioning
- Whether Arcus can differentiate itself in the competitive oncology space.
- Strategic Partnerships
- The pace at which Arcus secures new collaborations to advance its portfolio.
Related topics